JP2024520395A5 - - Google Patents

Info

Publication number
JP2024520395A5
JP2024520395A5 JP2023572622A JP2023572622A JP2024520395A5 JP 2024520395 A5 JP2024520395 A5 JP 2024520395A5 JP 2023572622 A JP2023572622 A JP 2023572622A JP 2023572622 A JP2023572622 A JP 2023572622A JP 2024520395 A5 JP2024520395 A5 JP 2024520395A5
Authority
JP
Japan
Prior art keywords
alkyl
alkylene
halogens
cycloalkyl
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023572622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520395A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/030839 external-priority patent/WO2022251302A1/en
Publication of JP2024520395A publication Critical patent/JP2024520395A/ja
Publication of JP2024520395A5 publication Critical patent/JP2024520395A5/ja
Pending legal-status Critical Current

Links

JP2023572622A 2021-05-26 2022-05-25 置換される縮合二環式大環状化合物および関連のある治療方法 Pending JP2024520395A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163193243P 2021-05-26 2021-05-26
US63/193,243 2021-05-26
PCT/US2022/030839 WO2022251302A1 (en) 2021-05-26 2022-05-25 Substituted fused bicyclic macrocyclic compounds and related methods of treatment

Publications (2)

Publication Number Publication Date
JP2024520395A JP2024520395A (ja) 2024-05-24
JP2024520395A5 true JP2024520395A5 (cg-RX-API-DMAC7.html) 2024-12-27

Family

ID=82851881

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023572622A Pending JP2024520395A (ja) 2021-05-26 2022-05-25 置換される縮合二環式大環状化合物および関連のある治療方法

Country Status (7)

Country Link
US (1) US20240182491A1 (cg-RX-API-DMAC7.html)
EP (1) EP4347046A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024520395A (cg-RX-API-DMAC7.html)
CN (1) CN117999265A (cg-RX-API-DMAC7.html)
AU (1) AU2022281345A1 (cg-RX-API-DMAC7.html)
CA (1) CA3219506A1 (cg-RX-API-DMAC7.html)
WO (1) WO2022251302A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4680611A1 (en) 2023-03-16 2026-01-21 Takeda Pharmaceutical Company Limited Macrocyclic heterocycle compounds and use thereof
JP2026518313A (ja) 2023-06-01 2026-06-04 ハー・ルンドベック・アクチエゼルスカベット スピロ大環状オレキシン2受容体アゴニスト
CN122374291A (zh) 2023-12-12 2026-07-10 爱杜西亚药品有限公司 作为食欲素受体调节剂的芳基砜及砜酮衍生物
WO2025132542A1 (en) 2023-12-19 2025-06-26 Idorsia Pharmaceuticals Ltd Macrocyclic orexin agonists
WO2026017128A1 (zh) * 2024-07-17 2026-01-22 江苏恩华药业股份有限公司 作为食欲素受体激动剂的环烯烃衍生物及其组合物和用途
US20260109711A1 (en) * 2024-09-18 2026-04-23 Vertex Pharmaceuticals Incorporated Macrocyclic sulfonamide modulators
US20260144795A1 (en) 2024-11-27 2026-05-28 H. Lundbeck A/S Spiromacrocyclic orexin 2 receptor agonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258163B2 (en) 2008-06-04 2012-09-04 Board Of Regents, The University Of Texas System Small-molecule agonists for type-2 orexin receptor
WO2014198880A1 (en) 2013-06-14 2014-12-18 Ferrer Internacional, S.A. 2-(2-aminophenoxy)-3-chloronaphthalene-1,4-dione compounds having orexin 2 receptor agonist activity
US20160250224A1 (en) 2013-09-24 2016-09-01 The Board Of Regents Of The University Of Texas System Orexin-control of bone formation and loss
WO2015073707A1 (en) 2013-11-15 2015-05-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating heart failure with agonists of hypocretin receptor 2
SG11201604639YA (en) 2013-12-12 2016-07-28 Univ Tsukuba Sulfonamide derivative or pharmaceutically acceptable acid addition salt thereof
JP6552117B2 (ja) 2014-03-28 2019-07-31 国立大学法人 筑波大学 敗血症の予防治療剤
SG11201806429PA (en) * 2016-02-04 2018-08-30 Takeda Pharmaceuticals Co Substituted piperidine compound and use thereof
WO2018053302A1 (en) * 2016-09-19 2018-03-22 Ensemble Therapeutics Corporation Macrocyclic compounds for the inhibition of indoleamine-2,3-dioxygenase activity and use thereof
MA47233A (fr) * 2016-12-19 2019-10-23 Epizyme Inc Composés hétérocycliques substitués par une amine utilisés comme inhibiteurs de l'ehmt2 et leurs méthodes d'utilisation
US11319286B2 (en) * 2017-08-03 2022-05-03 Takeda Pharmaceutical Company Limited Heterocyclic compound and application thereof
US10428023B2 (en) 2017-08-03 2019-10-01 Takeda Pharmaceutical Company Limited Heterocyclic compound and use thereof
CN110156813B (zh) * 2018-02-13 2023-07-25 北京诺诚健华医药科技有限公司 作为trk抑制剂的杂环化合物
CN110627812B (zh) * 2018-06-25 2022-10-11 北京诺诚健华医药科技有限公司 作为trk抑制剂的杂环化合物
EP3816154B1 (en) * 2018-06-29 2025-04-23 Takeda Pharmaceutical Company Limited Heterocyclic compound and application thereof
US11098029B2 (en) * 2019-02-13 2021-08-24 Merck Sharp & Dohme Corp. 5-alkyl pyrrolidine orexin receptor agonists
KR20260083444A (ko) * 2019-11-25 2026-06-05 알케르메스,인코포레이티드 치환된 마크로사이클릭 화합물 및 관련 치료 방법
EP4247801A4 (en) * 2020-11-23 2024-10-30 Merck Sharp & Dohme LLC 3-AMINO PYRROLIDINE AND MACROCYCLIC PIPERIDINE OREXIN RECEPTOR AGONISTS
US12006330B2 (en) * 2020-12-21 2024-06-11 Alkermes, Inc. Substituted macrocyclic compounds and related methods of treatment

Similar Documents

Publication Publication Date Title
JP2024501641A5 (cg-RX-API-DMAC7.html)
JP2024516633A5 (cg-RX-API-DMAC7.html)
JP6466348B2 (ja) スルファモイル−アリールアミドおよびb型肝炎を処置するための医薬品としてのその使用
JP2024520396A5 (cg-RX-API-DMAC7.html)
JP2023502441A5 (cg-RX-API-DMAC7.html)
JP2021512059A5 (cg-RX-API-DMAC7.html)
JP2024001048A5 (cg-RX-API-DMAC7.html)
JP2023520916A5 (cg-RX-API-DMAC7.html)
JP2021535112A5 (cg-RX-API-DMAC7.html)
JP2022545359A5 (cg-RX-API-DMAC7.html)
JP2006504766A5 (cg-RX-API-DMAC7.html)
JP2023554282A5 (cg-RX-API-DMAC7.html)
RU2009138600A (ru) Амиды диазабициклоалканов, селективные в отношении ацетилхолинового подтипа никотиновых рецепторов
JP2019510027A5 (cg-RX-API-DMAC7.html)
JP2022500425A5 (cg-RX-API-DMAC7.html)
JP2014510774A5 (cg-RX-API-DMAC7.html)
JP2009538910A5 (cg-RX-API-DMAC7.html)
JP2021102643A5 (cg-RX-API-DMAC7.html)
JP2025505644A5 (cg-RX-API-DMAC7.html)
JP2019501879A5 (cg-RX-API-DMAC7.html)
RU2008119651A (ru) Производные дикарбоновых кислот и их применение
JPWO2023195529A5 (cg-RX-API-DMAC7.html)
JP2023512557A5 (cg-RX-API-DMAC7.html)
JP2013542267A5 (cg-RX-API-DMAC7.html)
JP2020111571A5 (cg-RX-API-DMAC7.html)